Study Details

Back
Study ID E05-CL-3004
Study Title A Phase III, Double-blind, Randomized, Placebo-controlled, Multicenter Study Evaluating the Efficacy and Safety of QUTENZA® in Subjects with Painful Diabetic Peripheral Neuropathy (STEP)
Clinicaltrials.gov Identifier 01533428
Compound Name NGX-4010 (ASP0805) / capsaicin
Medical Indication or Disease Painful diabetic neuropathy
Study Sponsor Astellas Pharma Europe B.V. (APEBV)
Collaborator Not Applicable
Study Start Date 06-Feb-2012
Study Completion Date 13-Feb-2014
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS